Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
Authors:
Open Access
- 28 February 2023
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 23 (1) , 1-15
Abstract
Background: The immunological checkpoint known as Inducible T Cell Costimulatory Factor (ICOS, Cluster of Differentiation, CD278) is activated and expressed on T cells. Both somatic cells and antigen-presenting cells expressed its ligand, ICOSL (including tumor cells in the tumor microenvironment).It is important for immunosuppression. Uncertainty surrounds the function of ICOS in tumor immunity. Methods: Several bioinformatics techniques were employed by us to thoroughly examine the expression and prognostic value of ICOS in 33 cancers based on data collected from TCGA and GTEx. In addition, ICOS was explored with pathological stage, tumor-infiltrating cells, immune checkpoint genes, mismatch repair (MMR) genes, DNA methyltransferases (DNMTs), microsatellite instability (MSI),and tumor mutation burden (TMB).In addition,To ascertain the level of ICOS expression in various cells, qRT-PCR was employed. Results: The findings revealed that ICOS expression was up regulation in most cancer types. The high expression of ICOS in tumor samples was related to the poor prognosis of UVM and LGG; The positive prognosis was boosted by the strong expression of ICOS in OV, SARC, SKCM, THYM, UCEC, and HNSC. The result is that the expression of malignancy was revealed by the immune cells’ invasion.profile of ICOS in different types of cancer. Different ways that ICOS expression is connected to immune cell infiltration account for variations in patient survival. Additionally, the TMB, MSI, MMR, and DNMT genes as well as ICOS expression are linked in many cancer types.The results of PCR showed that it is highly expressed in gastric, breast, liver and renal cell carcinoma cell lines compared with normal cells. Conclusion: This study suggests that ICOS may be a potential tumor immunotherapy target and prognostic marker.Keywords
This publication has 51 references indexed in Scilit:
- Cancer immunotherapy: harnessing the immune system to battle cancerJournal of Clinical Investigation, 2015
- Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint RegulatorsFrontiers in Immunology, 2015
- Toward understanding and exploiting tumor heterogeneityNature Medicine, 2015
- Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacyCancer Science, 2015
- Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactionsCarcinogenesis, 2015
- Molecular Dissection of Microsatellite Instable Colorectal CancerCancer Discovery, 2013
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Microsatellite instability in colorectal cancer—the stable evidenceNature Reviews Clinical Oncology, 2010
- In situexpression and significance of B7 costimulatory molecules within tissues of human gastric carcinomaWorld Journal of Gastroenterology, 2003
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000